Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$237,912
-$4,160 QoQ
Shares Held
657
-4.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,731
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $8,063,885 across 15 Drug Manufacturers - General names. AMGN ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,004 | $2,265,766 | |
| 2 | JNJ |
Johnson & Johnson
|
7,699 | $1,955,315 | |
| 3 | NVS |
Novartis AG
|
6,281 | $984,358 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,494 | $705,979 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,283 | $541,114 | |
| 6 | LLY |
ELI LILLY & Co
|
450 | $539,743 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,281 | $304,291 | |
| 8 | AMGN |
Amgen Inc
This page
|
657 | $237,912 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,912 | 657 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $242,072 | 688 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $240,245 | 734 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $205,723 | 729 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $204,102 | 731 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $227,743 | 731 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $190,527 | 731 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $235,535 | 731 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $228,400 | 731 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $207,837 | 731 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $210,542 | 731 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $201,838 | 751 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $166,292 | 749 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $170,433 | 705 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $185,161 | 705 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $162,738 | 722 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $175,662 | 722 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $166,372 | 688 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $189,874 | 844 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $179,476 | 844 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $205,725 | 844 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $276,676 | 1,112 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $244,175 | 1,062 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $257,972 | 1,015 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $239,397 | 1,015 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $205,770 | 1,015 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||